Predictive Oncology updates ATM offering capacity to $18.33M under Form S-3 limit

Axe Compute Inc.

Filed prospectus supplement amending ATM agreement with H.C. Wainwright; maximum aggregate offering price set at $18.33M as of Oct 29, 2025.
Sold approximately $2.42M in common stock during prior 12 months under General Instruction I.B.6 of Form S-3.
If public float exceeds $75M, I.B.6 limit no longer applies, allowing larger sales without further supplement.
Legal opinion from DLA Piper LLP on shares issuable under ATM program attached as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.